Verfasser: |
Bosma, Angela L.
de Wijs, Linde E.M.
Hof, Michel H.
van Nieuwenhuizen, Beau R.
Gerbens, Louise A.A.
Middelkamp-Hup, Maritza A.
Hijnen, Dirk Jan
Spuls, Phyllis I. |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2021 |
Reihe/Periodikum: |
Bosma , A L , de Wijs , L E M , Hof , M H , van Nieuwenhuizen , B R , Gerbens , L A A , Middelkamp-Hup , M A , Hijnen , D J & Spuls , P I 2021 , ' Response to : “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry’” ' , Journal of the American Academy of Dermatology , vol. 85 , no. 3 , pp. e173-e174 . https://doi.org/10.1016/j.jaad.2021.02.072 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-26842005 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/d848a150-435a-4497-ad58-bb6a4b4b37e8 |